Insider Trading activities of Dexcom Inc insiders. , Part 6

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $4,721,044.
The total value of stock sales since 2005 is $539,675,318.
The total value of stock option exercises since 2005 is $34,498,305.



Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM) , Part 6
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 10.78 107,750
2014-02-10 Valdes Jorge A (CTO) Sale 16,000 38.03 608,496
2014-02-10 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-01-27 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 36.67 366,659
2014-01-27 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 14.30 143,000
2014-01-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 36.49 510,803
2014-01-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 3.19 44,660
2014-01-21 Roper Jess (VP, CFO) Sale 8,000 37.38 299,064
2014-01-21 Roper Jess (VP, CFO) Option Ex 8,000 3.19 25,520
2014-01-15 Gregg Terrance H (CEO) Sale 35,000 36.86 1,290,065
2014-01-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-01-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 37.37 373,700
2014-01-13 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 14.30 143,000
2014-01-08 Valdes Jorge A (CTO) Sale 16,000 35.36 565,728
2014-01-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2013-12-30 Topol Eric (Director) Option Ex 98,706 5.33 526,102
2013-12-18 Roper Jess (VP, CFO) Sale 8,000 34.48 275,808
2013-12-18 Roper Jess (VP, CFO) Option Ex 8,000 3.19 25,520
2013-12-13 Gregg Terrance H (CEO) Sale 5,000 34.50 172,500
2013-12-13 Gregg Terrance H (CEO) Option Ex 5,000 13.99 69,950
2013-12-12 Augustinos Nicholas (Director) Sale 11,321 34.41 389,499
2013-12-12 Gregg Terrance H (CEO) Sale 35,000 34.65 1,212,750
2013-12-12 Gregg Terrance H (CEO) Option Ex 35,000 3.19 111,650
2013-12-11 Gregg Terrance H (CEO) Sale 10,000 33.50 335,000
2013-12-11 Gregg Terrance H (CEO) Option Ex 10,000 7.31 73,100
2013-12-10 Augustinos Nicholas (Director) Sale 76,157 33.42 2,545,243
2013-12-10 Augustinos Nicholas (Director) Option Ex 48,000 7.27 348,960
2013-12-09 Augustinos Nicholas (Director) Sale 21,384 34.48 737,341
2013-12-09 Augustinos Nicholas (Director) Option Ex 21,384 7.27 155,461
2013-12-05 Gregg Terrance H (CEO) Sale 10,000 35.06 350,600
2013-12-05 Gregg Terrance H (CEO) Option Ex 10,000 7.31 73,100
2013-12-04 Gregg Terrance H (CEO) Sale 10,000 34.47 344,730
2013-12-04 Gregg Terrance H (CEO) Option Ex 10,000 7.31 73,100
2013-12-03 Balo Andrew K (SVP, Regulatory and Clinical) Sale 14,268 34.21 488,165
2013-12-02 Gregg Terrance H (CEO) Sale 9,000 34.51 310,590
2013-11-22 Kahn Barbara (Director) Sale 1,500 32.62 48,937
2013-11-19 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 23,000 32.11 738,576
2013-11-19 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 23,000 3.19 73,370
2013-11-15 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 7,000 32.60 228,200
2013-11-15 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 7,000 3.19 22,330
2013-11-15 Gregg Terrance H (CEO) Sale 15,000 32.53 487,890
2013-11-15 Gregg Terrance H (CEO) Option Ex 15,000 3.19 47,850
2013-11-14 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 5,000 33.32 166,595
2013-11-14 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 5,000 3.19 15,950
2013-11-14 Gregg Terrance H (CEO) Sale 10,000 32.50 325,000
2013-11-14 Gregg Terrance H (CEO) Option Ex 10,000 6.85 68,500
2013-11-13 Lister John (General Counsel, VP of HR) Sale 30,000 33.46 1,003,800
2013-11-13 Lister John (General Counsel, VP of HR) Option Ex 27,300 5.24 143,161
2013-11-13 Gregg Terrance H (CEO) Sale 10,000 33.29 332,890
2013-11-13 Gregg Terrance H (CEO) Option Ex 10,000 6.85 68,500
2013-11-12 Roper Jess (VP, CFO) Sale 3,000 33.44 100,305
2013-11-12 Valdes Jorge A (CTO) Sale 26,600 33.34 886,923
2013-11-12 Balo Andrew K (SVP, Regulatory and Clinical) Sale 26,784 33.15 887,889
2013-11-12 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 26,784 2.40 64,281
2013-11-11 Roper Jess (VP, CFO) Sale 15,000 32.62 489,254
2013-11-11 Roper Jess (VP, CFO) Option Ex 15,000 10.00 150,000
2013-11-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 15,438 33.17 512,032
2013-11-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 15,438 2.40 37,051
2013-11-01 Gregg Terrance H (CEO) Sale 9,000 28.33 254,969
2013-10-01 Gregg Terrance H (CEO) Sale 9,000 27.99 251,910
2013-09-03 Gregg Terrance H (CEO) Sale 9,000 27.00 243,000
2013-08-01 Gregg Terrance H (CEO) Sale 9,000 22.15 199,350
2013-07-01 Gregg Terrance H (CEO) Sale 9,000 22.87 205,812
2013-06-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 21.90 219,010
2013-06-13 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 2.40 24,000
2013-06-11 Lister John (General Counsel, VP of HR) Sale 2,000 22.43 44,860
2013-06-11 Roper Jess (VP, CFO) Sale 10,361 22.33 231,361
2013-06-11 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 5,000 22.31 111,550
2013-06-04 Gregg Terrance H (CEO) Sale 10,000 21.80 218,000
2013-06-03 Gregg Terrance H (CEO) Sale 9,000 20.79 187,128
2013-05-15 Moy Jeffrey (SVP, Operations) Sale 5,000 19.97 99,870
2013-05-15 Moy Jeffrey (SVP, Operations) Option Ex 5,000 3.19 15,950
2013-05-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 45,000 19.40 872,999
2013-05-13 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 45,000 2.40 108,000
2013-05-09 Doubleday Richard (SVP, Worldwide Sales) Sale 1,272 19.56 24,875
2013-05-01 Gregg Terrance H (CEO) Sale 9,000 16.84 151,596
2013-04-01 Gregg Terrance H (CEO) Sale 9,000 16.90 152,118
2013-03-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 15,416 16.53 254,811
2013-03-13 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 15,416 .50 7,708
2013-03-12 Valdes Jorge A (CTO) Sale 21,054 16.31 343,432
2013-03-11 Doubleday Richard (SVP, Worldwide Sales) Sale 5,100 15.63 79,697
2013-03-11 Lister John (VP of Legal Affairs) Sale 4,500 15.75 70,875
2013-03-11 Valdes Jorge A (CTO) Sale 2,000 15.58 31,162
2013-03-11 Skyler Jay S (Director) Buy 70,000 15.50 1,085,000
2013-03-08 Valdes Jorge A (CTO) Sale 1,000 15.61 15,610
2013-03-01 Gregg Terrance H (CEO) Sale 9,000 14.76 132,858
2013-02-28 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 25,000 14.99 374,850
2013-02-28 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 25,000 3.19 79,750
2013-02-27 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 20,000 15.01 300,100
2013-02-27 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 20,000 3.19 63,800
2013-02-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 30,000 14.95 448,350
2013-02-26 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 30,000 3.19 95,700
2013-01-02 Gregg Terrance H (CEO) Sale 9,000 13.89 125,010
2012-12-13 Valdes Jorge A (CTO) Sale 27,750 14.05 389,887
2012-12-13 Balo Andrew K (SVP, Regulatory and Clinical) Sale 12,760 13.97 178,244
2012-12-12 Valdes Jorge A (CTO) Sale 4,122 14.29 58,911
2012-12-11 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 10,000 14.27 142,650
2012-12-11 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 10,000 3.19 31,900
2012-12-10 Roper Jess (VP, CFO) Sale 8,715 13.84 120,633
2012-12-03 Gregg Terrance H (CEO) Sale 5,000 13.24 66,190
2012-11-05 Gregg Terrance H (CEO) Sale 5,000 12.76 63,800
2012-10-03 Gregg Terrance H (CEO) Sale 5,000 14.93 74,650
2012-09-14 Gregg Terrance H (CEO) Sale 9,000 13.50 121,500
2012-09-04 Gregg Terrance H (CEO) Sale 15,000 13.46 201,900
2012-08-31 Moy Jeffrey (SVP, Operations) Sale 10,000 13.30 133,000
2012-08-15 Moy Jeffrey (SVP, Operations) Sale 21,249 12.80 271,987
2012-08-03 Gregg Terrance H (CEO) Sale 5,000 11.60 57,980
2012-07-03 Gregg Terrance H (CEO) Sale 5,000 13.03 65,155
2012-06-04 Sayer Kevin R (President) Sale 12,077 10.68 128,934
2012-06-04 Gregg Terrance H (CEO) Sale 5,000 10.78 53,884
2012-05-18 Balo Andrew K (SVP, Regulatory and Clinical) Sale 14,198 10.46 148,482
2012-05-18 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 28,466 .50 14,233
2012-05-03 Gregg Terrance H (CEO) Sale 5,000 9.95 49,745
2012-04-03 Gregg Terrance H (CEO) Sale 5,000 10.63 53,175
2012-03-08 Doordan Martin (Director) Buy 2,000 10.36 20,710
2012-03-05 Gregg Terrance H (CEO) Sale 5,000 10.31 51,550
2012-02-03 Gregg Terrance H (CEO) Sale 5,000 11.71 58,545
2012-01-03 Gregg Terrance H (CEO) Sale 5,000 9.53 47,650
2011-12-13 Doordan Martin (Director) Buy 2,000 8.03 16,068
2011-11-18 Skyler Jay S (Director) Buy 8,000 7.09 56,760
2011-09-15 Doordan Martin (Director) Buy 2,000 12.35 24,708
2010-11-16 Gerhardsson Peter (VP, Int'l Bus. Dev.) Buy 2,400 11.85 28,449
2010-06-04 Valdes Jorge A (SVP of Operations) Buy 5,000 10.05 50,250
2010-05-17 Lord Jonathan T Md (Director) Buy 14,881 10.88 161,979
2010-05-14 Lord Jonathan T Md (Director) Buy 40,119 10.76 431,600
2010-05-13 Moy Jeffrey (V. P., Operations) Option Ex 6,606 6.98 46,109
2010-05-10 Gregg Terrance H (President and CEO) Buy 10,000 9.72 97,200
2010-03-15 Lucas Donald L Sale 10,000 9.79 97,920
2009-11-12 Gregg Terrance H (President and CEO) Buy 5,940 7.15 42,494
2009-11-10 Gregg Terrance H (President and CEO) Buy 14,060 7.20 101,274
2009-10-09 Moy Jeffrey (V. P., Operations) Option Ex 3,861 6.33 24,440
2009-08-13 Valdes Jorge A (SVP of Operations) Buy 5,000 6.84 34,225
2009-05-15 Graham Claudia (VP Marketing) Buy 2,500 4.08 10,200
2009-05-13 Gregg Terrance H (President and CEO) Buy 20,000 3.74 74,760
2009-05-12 Valdes Jorge A (SVP of Operations) Buy 5,000 3.74 18,700
2009-03-13 Gregg Terrance H (President and CEO) Buy 50,000 4.14 207,200
2009-03-11 Gregg Terrance H (President and CEO) Buy 20,800 3.74 77,875
2008-11-21 Graham Claudia (VP Marketing) Buy 7,000 1.51 10,584
2008-11-21 Roper Jess (VP, CFO) Buy 5,000 1.53 7,650
2008-11-21 Valdes Jorge A (SVP of Operations) Buy 3,250 1.49 4,829
2008-11-21 Balo Andrew K (SVP, Regulatory and Clinical) Buy 7,000 1.53 10,689
2008-11-21 Gregg Terrance H (President and CEO) Buy 35,000 1.57 54,810
2008-11-20 Graham Claudia (VP Marketing) Buy 9,000 1.69 15,237
2008-11-20 Gregg Terrance H (President and CEO) Buy 25,000 1.63 40,650
2008-11-19 Moy Jeffrey (V. P., Operations) Buy 50,000 2.00 100,000
2008-11-19 Pacelli Steven Robert (SVP, Corporate Affairs) Buy 5,000 2.00 10,000
2008-11-19 Valdes Jorge A (SVP of Operations) Buy 2,500 1.90 4,750
2008-11-19 Gregg Terrance H (President and CEO) Buy 40,000 1.93 77,080
2008-08-08 Gregg Terrance H (President & CEO) Buy 10,000 6.67 66,700
2008-03-14 Valdes Jorge A (SVP of Operations) Buy 2,000 4.87 9,738
2008-03-14 Gregg Terrance H (President and CEO) Buy 60,000 4.87 292,200
2008-03-14 Skyler Jay S (Director) Buy 20,000 4.97 99,400
2008-03-14 Nelson Glen D (Director) Buy 100,000 4.86 486,200
2008-03-14 Lucas Donald L (Director) Buy 35,000 4.91 171,885
2007-08-02 Lucas Donald A (Director) Sale 3,296 7.10 23,401
2007-03-15 Lucas Donald A (Director) Sale 4,000 7.17 28,700
2006-12-04 Lucas Donald A (Director) Sale 17,363 11.70 203,164
2006-07-26 Valdes Jorge A (Vice President of Engineering) Buy 3,000 11.20 33,600
2006-06-21 Brauker James H (VP, Research & Development) Option Ex 53,125 .40 21,250
2006-05-02 Kemper Steven J (Chief Financial Officer) Sale 75,000 24.00 1,800,000
2006-05-02 Brauker James H (VP Research & Development) Sale 82,500 24.00 1,980,000
2006-05-02 Rasdal Andrew P (President & CEO) Sale 125,000 24.00 3,000,000
2006-05-02 Rasdal Andrew P (President & CEO) Option Ex 125,000 .30 37,500
2006-05-02 Brister Mark (VP Advanced Development Teams) Sale 50,000 24.00 1,200,000
2006-05-02 Balo Andrew K (VP of Clinical & Regulatory) Sale 100,000 24.00 2,400,000
2006-05-02 Balo Andrew K (VP of Clinical & Regulatory) Option Ex 47,500 .40 19,000
2006-05-02 Split Rock Partners Llc (10% Owner) Sale 2,200,000 24.00 52,800,000
2006-05-02 Carney Sean (Director) Sale 400,000 24.00 9,600,000
2006-05-02 Lucas Donald L (Director) Sale 50,000 24.00 1,200,000
2006-05-02 Warburg Pincus Llc (10% Owner) Sale 400,000 24.00 9,600,000
2006-03-13 Blickenstaff Kim D (Director) Sale 10,000 18.55 185,509
2006-03-10 Blickenstaff Kim D (Director) Sale 10,648 18.48 196,775
2006-03-09 Blickenstaff Kim D (Director) Sale 20,000 18.31 366,140
2006-03-07 Nelson Glen D (Director) Option Ex 46,614 .50 23,307
2006-02-01 Brauker James H (VP, Research & Devel) Option Ex 14,375 .30 4,312
2006-01-05 Kemper Steven J (Chief Financial Officer) Option Ex 25,000 .50 12,500
2006-01-04 Lucas Donald L (Director) Option Ex 75,000 .50 37,500
2005-12-12 Blickenstaff Kim D (Chairman) Sale 4,000 14.59 58,348
2005-11-29 Blickenstaff Kim D (Chairman) Sale 8,000 14.59 116,744
2005-11-28 Blickenstaff Kim D (Chairman) Sale 1,900 14.53 27,607
2005-11-10 Waubeeka Llc (10% Owner) Sale 1,053,000 13.30 14,004,900
2005-11-10 Russo Guy M (10% Owner) Sale 1,053,000 13.30 14,004,900
2005-11-01 Split Rock Partners Llc (10% Owner) Sale 218,000 13.30 2,899,400
2005-10-25 Split Rock Partners Llc (10% Owner) Sale 611,000 12.05 7,362,550
2005-08-12 Skyler Jay S (Director) Buy 9,950 10.20 101,490
2005-04-13 Lucas Donald A (Director) Buy 6,500 12.00 78,000
2005-04-13 Skyler Jay S (Director) Buy 30,000 12.00 360,000

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.